Cargando…
Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
BACKGROUND: Treatment-induced cardiotoxicity is a leading noncancer-related cause of acute and late onset morbidity and mortality in cancer patients on antineoplastic drugs such as melphalan—increasing clinical case reports have documented that it could induce cardiotoxicity including severe arrhyth...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643439/ https://www.ncbi.nlm.nih.gov/pubmed/33153480 http://dx.doi.org/10.1186/s13287-020-01984-1 |
_version_ | 1783606279105675264 |
---|---|
author | Liu, Rui Li, Dong Sun, Fangxu Rampoldi, Antonio Maxwell, Joshua T. Wu, Ronghu Fischbach, Peter Castellino, Sharon M. Du, Yuhong Fu, Haian Mandawat, Anant Xu, Chunhui |
author_facet | Liu, Rui Li, Dong Sun, Fangxu Rampoldi, Antonio Maxwell, Joshua T. Wu, Ronghu Fischbach, Peter Castellino, Sharon M. Du, Yuhong Fu, Haian Mandawat, Anant Xu, Chunhui |
author_sort | Liu, Rui |
collection | PubMed |
description | BACKGROUND: Treatment-induced cardiotoxicity is a leading noncancer-related cause of acute and late onset morbidity and mortality in cancer patients on antineoplastic drugs such as melphalan—increasing clinical case reports have documented that it could induce cardiotoxicity including severe arrhythmias and heart failure. As the mechanism by which melphalan impairs cardiac cells remains poorly understood, here, we aimed to use cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) to investigate the cellular and molecular mechanisms of melphalan-induced cardiotoxicity. METHODS: hiPSC-CMs were generated and treated with clinically relevant doses of melphalan. To characterize melphalan-induced cardiotoxicity, cell viability and apoptosis were quantified at various treatment durations. Ca(2+) transient and contractility analyses were used to examine the alterations of hiPSC-CM function. Proteomic analysis, reactive oxygen species detection, and RNA-Sequencing were conducted to investigate underlying mechanisms. RESULTS: Melphalan treatment of hiPSC-CMs induced oxidative stress, caused Ca(2+) handling defects and dysfunctional contractility, altered global transcriptomic and proteomic profiles, and resulted in apoptosis and cell death. The antioxidant N-acetyl-l-cysteine attenuated these genomic, cellular, and functional alterations. In addition, several other signaling pathways including the p53 and transforming growth factor-β signaling pathways were also implicated in melphalan-induced cardiotoxicity according to the proteomic and transcriptomic analyses. CONCLUSIONS: Melphalan induces cardiotoxicity through the oxidative stress pathway. This study provides a unique resource of the global transcriptomic and proteomic datasets for melphalan-induced cardiotoxicity and can potentially open up new clinical mechanism-based targets to prevent and treat melphalan-induced cardiotoxicity. |
format | Online Article Text |
id | pubmed-7643439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76434392020-11-06 Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells Liu, Rui Li, Dong Sun, Fangxu Rampoldi, Antonio Maxwell, Joshua T. Wu, Ronghu Fischbach, Peter Castellino, Sharon M. Du, Yuhong Fu, Haian Mandawat, Anant Xu, Chunhui Stem Cell Res Ther Research BACKGROUND: Treatment-induced cardiotoxicity is a leading noncancer-related cause of acute and late onset morbidity and mortality in cancer patients on antineoplastic drugs such as melphalan—increasing clinical case reports have documented that it could induce cardiotoxicity including severe arrhythmias and heart failure. As the mechanism by which melphalan impairs cardiac cells remains poorly understood, here, we aimed to use cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) to investigate the cellular and molecular mechanisms of melphalan-induced cardiotoxicity. METHODS: hiPSC-CMs were generated and treated with clinically relevant doses of melphalan. To characterize melphalan-induced cardiotoxicity, cell viability and apoptosis were quantified at various treatment durations. Ca(2+) transient and contractility analyses were used to examine the alterations of hiPSC-CM function. Proteomic analysis, reactive oxygen species detection, and RNA-Sequencing were conducted to investigate underlying mechanisms. RESULTS: Melphalan treatment of hiPSC-CMs induced oxidative stress, caused Ca(2+) handling defects and dysfunctional contractility, altered global transcriptomic and proteomic profiles, and resulted in apoptosis and cell death. The antioxidant N-acetyl-l-cysteine attenuated these genomic, cellular, and functional alterations. In addition, several other signaling pathways including the p53 and transforming growth factor-β signaling pathways were also implicated in melphalan-induced cardiotoxicity according to the proteomic and transcriptomic analyses. CONCLUSIONS: Melphalan induces cardiotoxicity through the oxidative stress pathway. This study provides a unique resource of the global transcriptomic and proteomic datasets for melphalan-induced cardiotoxicity and can potentially open up new clinical mechanism-based targets to prevent and treat melphalan-induced cardiotoxicity. BioMed Central 2020-11-05 /pmc/articles/PMC7643439/ /pubmed/33153480 http://dx.doi.org/10.1186/s13287-020-01984-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Liu, Rui Li, Dong Sun, Fangxu Rampoldi, Antonio Maxwell, Joshua T. Wu, Ronghu Fischbach, Peter Castellino, Sharon M. Du, Yuhong Fu, Haian Mandawat, Anant Xu, Chunhui Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells |
title | Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells |
title_full | Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells |
title_fullStr | Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells |
title_full_unstemmed | Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells |
title_short | Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells |
title_sort | melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643439/ https://www.ncbi.nlm.nih.gov/pubmed/33153480 http://dx.doi.org/10.1186/s13287-020-01984-1 |
work_keys_str_mv | AT liurui melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT lidong melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT sunfangxu melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT rampoldiantonio melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT maxwelljoshuat melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT wuronghu melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT fischbachpeter melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT castellinosharonm melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT duyuhong melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT fuhaian melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT mandawatanant melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells AT xuchunhui melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells |